To begin to elucidate the potential implications of heightened serum levels of potent regulators of human TFH cell differentiation activin A and IL-21, we next tested whether serum from patients with ME/CFS could induce TFH cell differentiation of naive CD4+ T cells in vitro. The gene discussed is IL21; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.